Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Minimally invasive isolat… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Minimally invasive isolated limb perfusion - technical details and initial outcome of a new treatment method for limb malignancies

Artikel i vetenskaplig tidskrift
Författare Roger Olofsson Bagge
Per Carlson
Roya Razzazian
Christoffer Hansson
Anders Hjärpe
J. Mattsson
Dimitrios Katsarelias
Publicerad i International Journal of Hyperthermia
Volym 35
Nummer/häfte 1
Sidor 667-673
ISSN 0265-6736
Publiceringsår 2019
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för kirurgi
Institutionen för kliniska vetenskaper, Avdelningen för radiologi
Institutionen för kliniska vetenskaper
Sidor 667-673
Språk en
Länkar dx.doi.org/10.1080/02656736.2018.15...
Ämnesord Isolated limb perfusion, minimally invasive, ILP, MI-ILP, ILI, complete remission, cell lymphoma, actinomycin-d, melphalan, infusion, melanoma, extremity, survival, chemotherapy, multicenter, Oncology, Radiology
Ämneskategorier Cancer och onkologi

Sammanfattning

Objective: Isolated limb perfusion (ILP) and isolated limb infusion (ILI) are treatment options for patients with locally advanced melanomas and sarcomas of the extremities. ILP potentially have higher response rates, but requires open surgery for vascular access, whereas ILI is minimally invasive and easier to perform. We now present the technical details and outcome of a new approach to ILP by a minimally invasive vascular access (MI-ILP). Methods: Six patients, five with melanoma in-transit metastases and one with squamous cell carcinoma, were included in a phase I feasibility trial. Percutaneous vascular access of the extremity vessels was performed and the inserted catheters were then connected to a perfusion system. Results: All six treated patients underwent the procedure without the need for conversion to open surgery. The median operating time was 164 min and the median leakage rate was 0.1%. The complete response rate was 67%. Four patients (67%) had a Wieberdink grade II reaction and two patients (33%) had a grade III reaction. Conclusions: MI-ILP is feasible and gives the same treatment characteristics as open ILP, but with the advantage of a minimally invasive vascular access.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?